Neeraj Agarwal

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Neeraj Agarwal
Mar 30, 2025, 14:45 | Science
Daniela Castro: Impact of insurance status on survival outcomes in patients with mRCC
Daniela Castro, Clinical Research Associate of Medical Oncology at City of Hope, shared a post…
Mar 25, 2025, 17:13 | Insight
Sumanta K. Pal: Grateful to the amazing Huntsman Cancer Institute team for drawing me into this important work
Sumanta K. Pal, Vice Chair of Academic Affairs at City of Hope, shared Zeynep Irem…
Mar 22, 2025, 13:05 | Drugs
Zeynep Irem Ozay: Treatment and Attrition Trends for Metastatic Clear Cell Renal Cell Carcinoma in the US
Zeynep Irem Ozay, Postdoctoral Research Fellow at Huntsman Cancer Institute, shared an article she and her…
Mar 13, 2025, 07:45 | Science
Chiara Mercinelli: A comprehensive overview on the role of T-cell engagers in metastatic prostate cancer
Chiara Mercinelli, GU Medical Oncologist at IRCCS San Raffaele Hospital, shared an article by Chadi…
Mar 12, 2025, 11:34 | Science
Neeraj Agarwal: Overview of T-cell engagers in prostate cancer
Neeraj Agarwal, Professor of Medicine and a Presidential Endowed Chair of Cancer Research at the…
Feb 22, 2025, 05:18 | Blog
Francisco J. Esteva: The clinical applications of PARPi across various cancers
Francisco J. Esteva, Professor of Medicine at the Zucker School of Medicine, posted on LinkedIn…
Feb 20, 2025, 09:43 | Insight
Neeraj Agarwal: No OS or PFS benefit with SG in pretreated mUC bladder cancer
Neeraj Agarwal, Presidential Endowed Chair of Cancer Research at  Huntsman Cancer Institute, shared a post…
Feb 20, 2025, 09:35 | Insight
Louise Kostos: Combination Therapies in Locally Advanced PC and mHSPC
Louise Kostos, Medical Oncologist at Peter MacCallum Cancer Centre, shared a post on X about…
Feb 19, 2025, 16:42 | Blog
Dana-Farber Lank Center for Genitourinary Oncology Research Digest
Dana-Farber Lank Center for Genitourinary Oncology shared a post on X: "GU Research Digest for…
Feb 16, 2025, 04:20 | Societies
Highlights From Day 3 of ASCOGU25
The ASCO Genitourinary Cancers Symposium (ASCOGU25) is an annual event organized by the American Society of Clinical…
Feb 6, 2025, 15:27 | Insight
Georges Gebrael: Genomic biomarkers of survival in patients with mHSPC undergoing intensified ADT
Georges Gebrael, Research Fellow at Huntsman Cancer Institute and University of Utah, shared an article…
Feb 2, 2025, 01:49 | Blog
Neeraj Agarwal: 3 young investigators from the Huntsman Cancer Institute received the Conquer Cancer, the ASCO Foundation Merit Award
Neeraj Agarwal, Professor of Medicine and Presidential Endowed Chair of Cancer Research at the Huntsman…
Jan 25, 2025, 03:05 | Blog
Heterogeneity of the Treatment Effect with PARP Inhibitors in Metastatic Castration-resistant Prostate Cancer
Emre Yekedüz, Associate Professor of Medical Oncology at Ankara University, posted on X about recent paper…
Jan 21, 2025, 06:28 | Blog
ASCO Thanks Drs. Bertagnolli, Rathmell for Their Service Leading NIH, NCI
Tian Zhang shared a post by ASCO, on X: "Two extraordinary women leaders of NIH…
Jan 14, 2025, 02:46 | Blog
Germline and Somatic Genomic Testing for Metastatic Prostate Cancer
International Urology Cancer Summit shared on LinkedIn: " Here latest ASCO Clinical Practice Guideline: Germline and Somatic…
Jan 13, 2025, 19:30 | Insight
Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline
A recent paper by Evan Yu, Professor at the University of Washington, was mentioned by…
Jan 13, 2025, 17:53 | Blog
Neeraj Agarwal: Comprehensive review of efficacy and safety data of PARP inhibitors across cancer types
Neeraj Agarwal, Professor of Medicine, and a Presidential Endowed Chair of Cancer Research at the…
Dec 30, 2024, 04:50 | Blog
Improved survival rates for veterans with de novo mHSPC - Prostate Cancer Foundation
Prostate Cancer Foundation shared a post on X: "VA study shows improved survival rates for…
Dec 27, 2024, 17:02 | Insight
Toni Choueiri: Top 10 GU Bladder/Kidney Cancer Trials for 2024
Toni Choueiri, Director of the Lank Center for GU Oncology at Dana-Farber Cancer Institute, shared…
Dec 27, 2024, 14:18 | Science
The role of Nectin-4 as a predictive biomarker across genitourinary malignancies
An article was published in Journal of Clinical Oncology by Umang Swami et al.. "Assessing…
Dec 25, 2024, 02:41 | Insight
Correlating PSA Dynamics with Outcomes of Lutetium-177-PSMA-617 Treatment - European Urology
European Urology shared a post on X about a recent paper by Chadi Hage Chehade…
Dec 24, 2024, 16:14 | Blog
Karen Knudsen: Only 1/3 of patients receive 1L treatment intensification with an AR pathway inhibitor and/or docetaxel
Karen Knudsen shared on LinkedIn: "Prostate cancer remains the second leading cause of cancer-related deaths in…
Dec 23, 2024, 16:19 | Insight
Michael Hofman‘s top 10 publications from 2024 which ProsTic contributed to
Michael Hofman, Nuclear Medicine Physician at Melbourne’s Peter MacCallum Cancer Centre and Director of ProsTic,…
Dec 23, 2024, 06:08 | Science
Emanuele Crupi: N4 appears to be far more complex than we initially imagined
Emanuele Crupi, Fellow in Medical Oncology at San Raffaele University-Hospital, shared a post on LinkedIn,…
Dec 22, 2024, 17:23 | Science
Zeynep Irem Ozay: Assessing nectin-4 as a predictive biomarker in GU malignancies
Zeynep Irem Ozay, Postdoctoral Research Fellow at Huntsman Cancer Institute, posted on X about recent…
Dec 13, 2024, 18:54 | Blog
Neeraj Agarwal: Fantastic keynote talk on RCC kidney cancer by Sumanta K. Pal
Neeraj Agarwal, Professor of Medicine, and a Presidential Endowed Chair of Cancer Research at the…
Dec 5, 2024, 00:13 | Insight
Alan Bryce: The manuscript from the 2024 United States Prostate Cancer Consensus Conference
Alan Bryce, Chief Clinical Officer at City of Hope Phoenix, shared a post on X…
Dec 4, 2024, 17:57 | Insight
Neeraj Agarwal on T-cell engager therapies - Prostate Cancer Foundation
Prostate Cancer Foundation posted the following on X: “T-cell engager therapies act like a bridge,…
Dec 4, 2024, 15:19 | Blog
Neeraj Agarwal: Consensus statement from 2024 United States Prostate Cancer Conference
Neeraj Agarwal, Professor of Medicine and Presidential Endowed Chair of Cancer Research at the Huntsman…
Dec 1, 2024, 15:25 | Blog
Yüksel Ürün: An honor and joy to be featured in The ASCO Post
Yüksel Ürün, Medical Oncology Professor at Ankara University School of Medicine, shared a post on X:…
Nov 22, 2024, 21:35 | Blog
Axel S. Merseburger: Post hoc analysis of TITAN
Axel S. Merseburger, Professor of Urology and Chairman of the Department of Urology at University…
Nov 20, 2024, 00:16 | Blog
Aparna Sharma: Upcoming Academic Extravaganza in Genitourinary Oncology
Aparna Sharma, Assistant Professor in Department of Medical Oncology at All India Institute of Medical…
Nov 12, 2024, 18:46 | Insight
Neeraj Agarwal: Changing the diagnostic paradigm of ccRCC
Neeraj Agarwal, Professor of Medicine and Presidential Endowed Chair of Cancer Research at the Huntsman…
Nov 10, 2024, 03:09 | Blog
Umang Swami: Patient-level analysis of ph3 SWOG 1216 trial in mHSPC
Umang Swami, Assistant Professor in the Division of Oncology at the Huntsman Cancer Institute, shared…
Nov 3, 2024, 17:46 | Insight
Rana McKay: Evaluating ACP1 expression in prostrate cancer
Rana McKay, Associate Professor of Medicine at UC San Diego, shared on X: “So proud…
Oct 31, 2024, 12:49 | Blog
Neeraj Agarwal: Why Words Matter in Advanced Prostate Cancer
Neeraj Agarwal, Professor of Medicine, and a Presidential Endowed Chair of Cancer Research at the…
Oct 27, 2024, 16:43 | Blog
Neeraj Agarwal: Premier symposium on Transformation in Cancer Care Delivery
Neeraj Agarwal, Professor of Medicine, and a Presidential Endowed Chair of Cancer Research at the…
Oct 22, 2024, 09:38 | Societies
Highlights from the Fall 2024 SWOG Group Meeting
The Fall 2024 SWOG Group Meeting was held from October 16 to 19, 2024, at…
Oct 20, 2024, 17:29 | Blog
Tian Zhang: Fantastic pearls of wisdom for clinical researchers from Neeraj Agarwal
Tian Zhang, shared a post on X by Umang Swami, Assistant Professor in the Division…
Oct 20, 2024, 10:49 | Blog
Neeraj Agarwal: Taking the microbiome modulation in cancer therapy to the next level
Neeraj Agarwal shared a post on X: "Taking the microbiome modulation in cancer therapy to…
Oct 19, 2024, 17:18 | Positive
Umang Swami has been awarded the SWOG Dr. Vogelzang Scholar Award
The Nicholas Vogelzang SWOG GU Scholarship supports early-stage investigators in genitourinary cancers, allowing them to…
Oct 19, 2024, 12:33 | Blog
Neeraj Agarwal: Don S. Dizon on improving accrual of diverse patients on trials
Neeraj Agarwal shared on X: ''Terrific talk by the legend Don S. Dizon on improving accrual…
Oct 18, 2024, 19:05 | Blog
Thomas Flaig: The art of patient enrollment in clinical trials
Thomas Flaig posted on X: "Wonderful and practical discussion on the art of patient enrollment…
Oct 14, 2024, 15:14 | Drugs
Toni Choueiri: Talazoparib with or without enzalutamide in mCRPC
Toni Choueiri shared on X: ''JUST IN: HUGE NEWS ==> OS benefit from TALAPRO-2 study…
Oct 12, 2024, 22:08 | Insight
Sumanta Pal: The 1st study to show an OS benefit with ARPI + PARP in mCRPC
Sumanta Pal shared a post on X: “Woke up to this incredible news from the…
Oct 3, 2024, 13:00 | Positive
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
September was a significant month dedicated to raising awareness about various cancers, and Prostate Cancer…
Oct 1, 2024, 14:10 | Blog,Opinion
Yüksel Ürün: Congratulations to Aruni Ghose and team for winning the Best Poster Award
Aruni Ghose shared a post by Yüksel Ürün, on X: ''Meet URO Italy to International…
Oct 1, 2024, 14:05 | Blog
Aruni Ghose: The Right Conference at the Right Time for the Right Audience and the Right Purpose by the Right People
Aruni Ghose shared a post by Giuseppe Banna, Consultant Medical Oncologist at Portsmouth Hospitals University…
Sep 29, 2024, 15:31 | Insight
Neeraj Agarwal: Excellent systematic review on treatment in Metastatic Castration-resistant Prostate Cancer by Edoardo Francini
Neeraj Agarwal shared a post on X: "Just in European Urology. Kudos to the stellar leadership…
Sep 29, 2024, 09:49 | Blog
Adjuvant Everolimus in Patients with Completely Resected, High-risk Renal Cell Carcinoma - European Urology
European Urology shared on X: "Platinum Priority - Kidney Cancer: Adjuvant Everolimus in Patients with…
Sep 28, 2024, 09:07 | Blog
Neeraj Agarwal: Intensification and de-intensification in treatment of mRCC by Sumanta K. Pal at IUCS24
Neeraj Agarwal shared on X: "Intensification and de-intensification in treatment of mRCC kidney cancer. Fantastic…
Sep 28, 2024, 08:24 | Blog
Sumanta K. Pal: Cannot say enough how much I learn about prostate cancer every time I hear Neeraj Agarwal
Sumanta K. Pal shared a post by Yüksel Ürün on X, adding: "Cannot say enough…
Sep 26, 2024, 16:11 | Blog
Chandler Park: Learning the latest cutting edge data to help our cancer patients at ESMO 24
Chandler Park shared a post on Linkedin: ''ESMO was FUN! Loved learning the latest cutting…
Sep 26, 2024, 11:40 | Blog
Neeraj Agarwal: Join the second International Urology Cancer Summit
Neeraj Agarwal shared a post on X: "At the IUCS24 The International Urology Cancer Summit this…
Sep 23, 2024, 14:21 | Blog
Albert Jang: First ESMO24 experience in Barcelona
Albert Jang, Internal Medicine Resident at Tulane University School of Medicine, shared on X: ''Had…
Sep 20, 2024, 12:57 | Blog
Neeraj Agarwal: The 1st results of the ph3 Niagara trial of cisplatin + gemcitabine +/- durvalumab in MIBC
Neeraj Agarwal shared a post on X: "Breaking news (practice changing) from ESMO24, Tom Powles…
Sep 19, 2024, 14:05 | Blog
Yuksel Urun: The conference rooms are no longer enough for GU sessions at ESMO 24
Petros Grivas shared a post by Yuksel Urun on X: "Thrilled to co-chair GU session…
Sep 19, 2024, 04:32 | Societies
Best of ESMO24
The ESMO Congress 2024 took place in Barcelona, from September 13 to 17, 2024, at…
Sep 17, 2024, 18:42 | Blog
Neeraj Agarwal: The stats on the ESMO24 meeting at the presidential dinner
Neeraj Agarwal shared a post on X: "ESMO presidential dinner. ESMO President Andres Cervantes provided the…
Sep 17, 2024, 10:06 | Insight
Sumanta K. Pal: Important analysis of SWOG 1500 published just ahead of ESMO24
Sumanta K. Pal shared a post on X: "Huge congrats to Pedro C Barata, who drove…
Sep 16, 2024, 16:31 | Societies
40 Posts Not To Miss From ESMO24 Day 3
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at the…
Sep 15, 2024, 15:58 | Blog
OncoInfluencers to Follow on Social Media: Dr. Neeraj Agarwal
We are delighted to feature Dr. Neeraj Agarwal as a key figure in the oncology…
Sep 15, 2024, 12:53 | Blog
Sumanta Pal's highlights from ESMO24
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at the…
Sep 14, 2024, 17:15 | Societies
45 Posts not to miss from ESMO24 Day 1
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at…
Sep 14, 2024, 13:44 | Societies
Neeraj Agarwal's highlights from ESMO24
The ESMO Congress 2024 (ESMO24) is one of the most globally influential platforms in oncology,…
Sep 13, 2024, 07:51 | Blog
Neeraj Agarwal: Zr-girentuximab PET–CT for detecting ccRCC
Neeraj Agarwal shared a post on X, about recent paper published in The Lancet Oncology:…
Sep 7, 2024, 15:45 | Blog
Dimitra R. Bakaloudi: Evaluating TMB and MSI in patients with Urothelial cancer treated with ICIs
Dimitra R. Bakaloudi, Postdoctoral GU Oncology Researcher at University of Washington, shared on X about…
Sep 7, 2024, 10:04 | Blog
Jun Gong: Selective omission of RT in rectal cancer
Jun Gong, Medical Oncologist and Researcher in Gastrointestinal and Genitourinary cancers at Cedars-Sinai, shared on X:…
Sep 1, 2024, 08:30 | Insight
Sacituzumab Govitecan in cisplatin-ineligible metastatic urothelial cancer after CPI
TROPHY-U-01 Cohort 2: A Phase II Study of Sacituzumab Govitecan in Cisplatin-Ineligible Patients With Metastatic…
Aug 18, 2024, 08:27 | Blog
Enrique Grande: Amazing review from Rana McKay and Neeraj Agarwal on the new PARPi + ARSIs combos
Enrique Grande posted on X about recent paper by Rana McKay et al., titled "First-line…
Aug 11, 2024, 12:27 | Insight
Avirup Guha: SDOH's impact on hypertension control in cancer patients
Avirup Guha, Director of Cardio-Oncology at Georgia Cancer Center, shared on X about a recent…
Aug 10, 2024, 14:33 | Insight
Importance of early genetic testing for prostate cancer patients
Kenrick Ng, Consultant in Medical Oncology at Barts Health NHS Trust, shared on X about…
Aug 10, 2024, 12:17 | Insight
Emmanuel Antonarakis: Most compelling study suggesting that combined Abiraterone and Olaparib is better than sequential Abiraterone and Olaparib for 1st-line mCRPC
Emmanuel Antonarakis, Professor of Medicine at the University of Minnesota, shared a post on X…
Aug 5, 2024, 02:16 | Blog
Neeraj Agarwal: Biomarker based treatment of bladder cancer
Neeraj Agarwal shared a post on X: "Biomarker based treatment of bladder cancer. Enjoyed the…
Aug 5, 2024, 01:55 | Societies
Scientific Committees at the ESMO Congress 2024
The ESMO Congress is a globally influential oncology platform that brings together clinicians, researchers, patient…
Aug 4, 2024, 17:24 | Blog
Neeraj Agarwal: Liquid epigenomic profiling to diagnose RCC patients with residual disease surgery
Neeraj Agarwal shared on X: "Another stellar talk by David Braun in World GU Conference…
Aug 4, 2024, 16:52 | Insight
Future of ADCs and targeted therapies in bladder cancer
Neeraj Agarwal shared a post on X: “Future of ADCs and targeted therapies in bladder…
Aug 4, 2024, 14:30 | Societies
8 Posts Not To Miss From GUWorld24!
The 2024 World Conference On Genitourinary Cancers (GUWorld24) took place from August 1st to 3rd…
Aug 4, 2024, 12:48 | Insight
Neeraj Agarwal: Recommendations on bladder preservation in MIBC at the WorldGU24
Neeraj Agarwal shared on X: “Recommendations on bladder preservation in MIBC bladder-cancer by the IBCG…
Jul 25, 2024, 13:04 | Blog
Enrique Grande: Failure of Trials to Enhance Outcomes in mRCC Patients Re-challenged with Immunotherapy
Enrique Grande shared a post on X: "2 phase 3 trials have failed to improve…
Jul 24, 2024, 13:22 | Insight
Neeraj Agarwal: Unacceptably low rates of NGS testing in metastatic Prostate Cancer
Neeraj Agarwal shared a post on X about a recent paper by Chadi Hage Chehade…
Jul 24, 2024, 13:13 | Blog
Earle Burgess: Bipolar androgen therapy for advanced prostate cancer
Earle Burgess, Genitourinary Medical Oncologist, Atrium Health Levine Cancer Institute, shared on LinkedIn: "Bipolar androgen therapy…
Jul 21, 2024, 20:01 | Blog
Assessing bone pain and survival in SWOG Cancer Research Network 1216 TAK700 in hormone sensitive prostate cancer
Sumanta K.Pal shared a post on X about a recent paper by Georges Gebrael et al.,…
Jul 21, 2024, 10:58 | Blog
Chadi Hage Chehade: NGS testing rates in patients with metastatic prostate and urothelial cancers
Petros Grivas shared a post by Chadi Hage Chehade, Post-Doctoral Research Fellow at Huntsman Cancer Institute, on X:…
Jul 20, 2024, 21:28 | Blog
Pedro C Barata: More awesome news for patient with mCRPC
Pedro C Barata, GU Med Oncologist at University Hospitals Seidman Cancer Center, posted on X:…
Jul 20, 2024, 01:26 | Blog
Two recent papers studying BRAF alterations in PCa
Recently two papers have been published about BRAF alterations in prostate cancer: Unique Spectrum of…
Jul 14, 2024, 06:27 | Blog
Georges Gebrael: Baseline bone pain associated with lower survival in mHSPC
Georges Gebrael, Research Fellow at Huntsman Cancer Institute and University of Utah, shared on X/Twitter:…
Jul 14, 2024, 03:00 | Insight
Comprehensive talk on treatment options in adjuvant RCC by Bradley McGregor
Neeraj Agarwal shared on X: "Emerging treatment options in adjuvant RCC kidney cancer setting, comprehensive…
Jul 13, 2024, 20:46 | Blog
Yüksel Ürün: Outstanding presentation at KCRS24 Rohit Mehra
Yüksel Ürün shared on X: "Outstanding presentation at KCRS 24 Rohit Mehra Role of Pathologist…
Jul 12, 2024, 16:05 | Insight
Piotr Wysocki: Bone Pain and Survival Among Patients With mHSPC
Piotr Wysocki recently posted on LinkedIn: "Bone pain is linked to worse overall survival (OS) in…
Jul 12, 2024, 13:32 | Societies
Insights from KCRS24 by Neeraj Agarwal
Kidney Cancer Research Summit or the KCRS24 was a conference held on 11th-12th July in…
Jul 11, 2024, 11:33 | Blog
Neeraj Agarwal: Outstanding talk by Evan Yu on treatment of advanced prostate cancer
Neeraj Agarwal shared a post on X: “Enjoyed the outstanding talk by Evan Yu at…
Jul 11, 2024, 10:12 | Blog
Shilpa Gupta: Stellar talk by Neeraj Agarwal on tremendous progress in mCRpC in Athens
Shilpa Gupta shared a post on X: “Stellar talk by Neeraj Agarwal on tremendous progress…
Jul 11, 2024, 03:10 | Blog
Neeraj Agarwal: A terrific whirlwind tour of bladder cancer treatment landscape by Shilpa Gupta
Neeraj Agarwal shared a post on X: “A terrific whirlwind tour of bladder cancer treatment…
Jul 8, 2024, 12:15 | Insight
Neeraj Agarwal: Authoritative talk on systemic treatment of penile cancer by Andrea Necchi
Neeraj Agarwal shared a post on X: "Authoritative talk on systemic treatment of penile cancer…
Jul 8, 2024, 12:07 | Blog
Shilpa Gupta: Kudos to Philippe Spiess and Andrea Necchi on the successes of Global Society of Rare GU Tumors
Shilpa Gupta shared on X: "The amazing Philippe Spiess kicks off the session on rare…
Jul 4, 2024, 12:08 | Societies
Neeraj Agarwal and Rana McKay highlight key studies in urothelial and renal cell carcinomas
The American Society of Clinical Oncology (ASCO) shared on X: "Neeraj Agarwal of Huntsman Cancer…
Jul 3, 2024, 23:28 | Insight
Neeraj Agarwal: Amazing performance by the stellar Genitourinary Cancer Research Team's junior investigators
Neeraj Agarwal shared a post on X: "Amazing performance by the stellar Genitourinary Cancer Research…
Jul 1, 2024, 12:00 | Blog
Shilpa Gupta: Congrats Neeraj Agarwal on another stellar achievement
Shilpa Gupta shared on X/Twitter: "Congrats Neeraj Agarwal on yet another stellar achievement! And for…
Jun 24, 2024, 01:48 | Insight
Novel PARP inhibitor saruparib in metastatic hormone-sensitive prostate cancer
UroToday shared a post on X:           . "The EvoPAR-Prostate 01 Trial:…
12
All: 135 Posts: 1 - 100
Special Coverage